Skip to main content
Premium Trial:

Request an Annual Quote

The Genetics Company, Discovery Partners to Screen Drug Candidates for Colon Cancer

NEW YORK, Sept. 24 – The Genetics Company and Discovery Partners have partnered to identify potential drug targets for colon cancer, the companies said on Monday.

Discovery Partners, of San Diego, will screen thousands of chemical compounds for their ability to inhibit a protein that The Genetics Company has in previous studies linked to colon cancer.

The agreement calls for The Genetics Company, of Zurich, Switzerland, to hold patent rights to any drug candidates that result from the research. In return, the company will pay Discovery Partners milestone payments and fees, including those for completed experiments and access to the substance libraries.

Further financial details were not disclosed.

The Genetics Company, which is privately held, uses its mouse and fruit fly model systems in functional genomics to help discover new drug targets. In addition to colon cancer, the company hopes to develop therapeutic compounds for endocrine disorders, inflammatory conditions, tissue regeneration, parasites, and other cancers.

In May, Discovery Partners completed its $1.7 million acquisition of Xenometrix , a Colorado-based developer of assays for screening drug candidates.

The Scan

Guidelines for Ancient DNA Work

More than two dozen researchers have developed new ethical guidelines for conducting ancient DNA research, which they present in Nature.

And Cleared

A UK regulator has cleared former UK Prime Minister David Cameron in concerns he should have registered as a consultant-lobbyist for his work with Illumina, according to the Financial Times.

Suit Over Allegations

The Boston Globe reports that David Sabatini, who was placed on leave from MIT after allegations of sexual harassment, is suing his accuser, the Whitehead Institute, and the institute's director.

Nature Papers on Esophageal Cancer, Origin of Modern Horses, Exome Sequencing of UK Biobank Participants

In Nature this week: genetic and environmental influences of esophageal cancer, domestic horse origin traced to Western Eurasian steppes, and more.